Cargando…
Adipose-Derived Mesenchymal Stem Cells Alleviate Hypertrophic Scar by Inhibiting Bioactivity and Inducing Apoptosis in Hypertrophic Scar Fibroblasts
Background: As a fibrotic disease with a high incidence, the pathogenesis of hypertrophic scarring is still not fully understood, and the treatment of this disease is also challenging. In recent years, human adipose-derived mesenchymal stem cells (AD-MSCs) have been considered an effective treatment...
Autores principales: | Li, Shiyi, Yang, Jinxiu, Sun, Jiachen, Chen, Minliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776926/ https://www.ncbi.nlm.nih.gov/pubmed/36552789 http://dx.doi.org/10.3390/cells11244024 |
Ejemplares similares
-
Shikonin promotes hypertrophic scar repair by autophagy of hypertrophic scar-derived fibroblasts
por: Zhang, Qing, et al.
Publicado: (2023) -
Autologous chyle fat grafting for the treatment of hypertrophic scars and scar-related conditions
por: Xu, Xiao, et al.
Publicado: (2018) -
Mesenchymal stem cell therapy in hypertrophic and keloid scars
por: Bojanic, Christine, et al.
Publicado: (2021) -
Use of Adipose Stem Cells Against Hypertrophic Scarring or Keloid
por: Chen, Hongbo, et al.
Publicado: (2022) -
Adipose-derived mesenchymal stem cells inhibit cell proliferation and migration and suppress extracellular matrix synthesis in hypertrophic-scar and keloid fibroblasts
por: Xie, Fang, et al.
Publicado: (2021)